Most infants born with otoferlin deafness get cochlear implants in infancy and so are thus ineligible for that trial. The implants somewhat change the cochlea, which could hamper the interpretation of gene therapy results. “There has never been a Organic or healthcare or surgical technique to appropriate the underlying https://artsuppliesonline.us/